From: Cost-effectiveness of a hypertension management programme in an elderly population: a Markov model
Cost Variables | Base case | Distribution type | Distribution |
---|---|---|---|
Usual care | |||
Cost drugs/year | 206.43 | Lognormal | (4.36; 1.39) |
Cost diagnostic/follow-up tests per year | 29.10 | Uniform | (20.37;37.83) |
Number of medical visits | 7.68 | Lognormal | (1.68; 0.89) |
Hypertension programme | |||
Cost drugs/year | 216.55 | Lognormal | (4.59; 1.26) |
Cost diagnostic/follow-up tests per year | 36.19 | Uniform | (25.33; 47.04) |
Cost programme | 14.66 | Uniform | (10.26; 19.06) |
Number of medical visits | 4.72 | Lognormal | (1.16; 0.85) |
Common variables | |||
Overhead cost (per visit) | 1.98 | Uniform | (1.39; 2.57) |
Cost per medical visit | 9.63 | Uniform | (6.74; 12.52) |
Cost ambulance/year | 17.44 | Uniform | (12.21;22.67) |
Proportion of drugs coverage | 0.70 | Uniform | (0.40; 1.00) |
Cost of cardiovascular event attention | 10041.65 | Lognormal | (8.24; 1.39) |
Cost of diagnostic tests first year | 117.78 | Uniform | (82.44;153.11) |